BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 29914019)

  • 1. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S
    J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
    Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
    J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
    Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM
    Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    Martins IV; Rivers-Auty J; Allan SM; Lawrence CB
    J Alzheimers Dis; 2017; 55(3):915-932. PubMed ID: 27802235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD).
    Filali M; Lalonde R; Theriault P; Julien C; Calon F; Planel E
    Behav Brain Res; 2012 Oct; 234(2):334-42. PubMed ID: 22796601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic-like memory for what-where-which occasion is selectively impaired in the 3xTgAD mouse model of Alzheimer's disease.
    Davis KE; Easton A; Eacott MJ; Gigg J
    J Alzheimers Dis; 2013; 33(3):681-98. PubMed ID: 23034524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
    Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
    J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference and working memory deficits in the 3xTg-AD mouse between 2 and 15-months of age: a cross-sectional study.
    Stevens LM; Brown RE
    Behav Brain Res; 2015 Feb; 278():496-505. PubMed ID: 25446812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.
    Sterniczuk R; Antle MC; Laferla FM; Dyck RH
    Brain Res; 2010 Aug; 1348():149-55. PubMed ID: 20558146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated cognitive stimulation alleviates memory impairments in an Alzheimer's disease mouse model.
    Martinez-Coria H; Yeung ST; Ager RR; Rodriguez-Ortiz CJ; Baglietto-Vargas D; LaFerla FM
    Brain Res Bull; 2015 Aug; 117():10-5. PubMed ID: 26162480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
    Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
    Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.